North America Postpartum Depression Drugs Market Size, Share & Trends Analysis Report By Treatment (Pharmacotherapy, Hormonal Therapy, and Others), By Route of Administration, By Distribution Channel, By Type, By Country and Growth Forecast, 2024

List of Tables

The North America Postpartum Depression Drugs Market would witness market growth of 8.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Postpartum Depression Drugs Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $446.7 million by 2031. The Canada market is experiencing a CAGR of 10.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.3% during (2024 - 2031).

Postpartum depression (PPD) treatment involves a multifaceted approach aimed at alleviating symptoms, improving maternal mental health, and supporting overall well-being during the postpartum period. Treatment strategies for PPD typically include a combination of pharmacological interventions, psychotherapeutic support, lifestyle modifications, and social support networks.

Postpartum depression drugs, also known as antidepressants, are medications prescribed to manage and alleviate symptoms of postpartum depression (PPD) experienced by women following childbirth. These medications are pivotal in correcting biochemical imbalances in the brain that contribute to mood disruptions. The primary application of postpartum depression drugs is to treat the symptoms of depression experienced by mothers during the postpartum period.

The Mexican government, through agencies like CONACYT (Consejo Nacional de Ciencia y Tecnologia), provides funding and support for medical research, including studies aimed at developing new pharmaceutical treatments for PPD. This support accelerates the pace of innovation and ensures that new treatments are accessible to the Mexican population. Pharmaceutical companies in Mexico collaborate closely with healthcare providers and mental health professionals to understand the unique challenges and needs of Mexican women facing PPD. This collaboration facilitates the development of treatments that are effective in the local context and ensures proper implementation and monitoring. Therefore, rising medical research & innovation and increasing budget on mental health of women in the region is driving the growth of the market.

Based on Treatment, the market is segmented into Pharmacotherapy, Hormonal Therapy, and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Type, the market is segmented into Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder (OCD), Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder (PTSD), and Postpartum Psychosis. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Pfizer, Inc.
Eli Lilly And Company
Novartis AG
GlaxoSmithKline PLC (GSK)
Merck & Co., Inc.
Biogen, Inc.
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies, Inc.(DermTech, Inc.)
Cipla Limited
Sage Therapeutics, Inc.

North America Postpartum Depression Drugs Market Report Segmentation

By Treatment

Pharmacotherapy
Hormonal Therapy
Others

By Route of Administration

Oral
Parenteral
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Type

Postpartum Anxiety
Postpartum Blues
Postpartum Obsessive-Compulsive Disorder (OCD)
Postpartum Panic Disorder
Postpartum Post-Traumatic Stress Disorder (PTSD)
Postpartum Psychosis

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Postpartum Depression Drugs Market, by Treatment
- 1.4.2 North America Postpartum Depression Drugs Market, by Route of Administration
- 1.4.3 North America Postpartum Depression Drugs Market, by Distribution Channel
- 1.4.4 North America Postpartum Depression Drugs Market, by Type
- 1.4.5 North America Postpartum Depression Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Postpartum Depression Drugs Market by Treatment

4.1 North America Pharmacotherapy Market by Country
4.2 North America Hormonal Therapy Market by Country
4.3 North America Others Market by Country

Chapter 5. North America Postpartum Depression Drugs Market by Route of Administration

5.1 North America Oral Market by Country
5.2 North America Parenteral Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Postpartum Depression Drugs Market by Distribution Channel

6.1 North America Hospital Pharmacy Market by Country
6.2 North America Retail Pharmacy Market by Country
6.3 North America Online Pharmacy Market by Country

Chapter 7. North America Postpartum Depression Drugs Market by Type

7.1 North America Postpartum Anxiety Market by Country
7.2 North America Postpartum Blues Market by Country
7.3 North America Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country
7.4 North America Postpartum Panic Disorder Market by Country
7.5 North America Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country
7.6 North America Postpartum Psychosis Market by Country

Chapter 8. North America Postpartum Depression Drugs Market by Country

8.1 US Postpartum Depression Drugs Market
- 8.1.1 US Postpartum Depression Drugs Market by Treatment
- 8.1.2 US Postpartum Depression Drugs Market by Route of Administration
- 8.1.3 US Postpartum Depression Drugs Market by Distribution Channel
- 8.1.4 US Postpartum Depression Drugs Market by Type
8.2 Canada Postpartum Depression Drugs Market
- 8.2.1 Canada Postpartum Depression Drugs Market by Treatment
- 8.2.2 Canada Postpartum Depression Drugs Market by Route of Administration
- 8.2.3 Canada Postpartum Depression Drugs Market by Distribution Channel
- 8.2.4 Canada Postpartum Depression Drugs Market by Type
8.3 Mexico Postpartum Depression Drugs Market
- 8.3.1 Mexico Postpartum Depression Drugs Market by Treatment
- 8.3.2 Mexico Postpartum Depression Drugs Market by Route of Administration
- 8.3.3 Mexico Postpartum Depression Drugs Market by Distribution Channel
- 8.3.4 Mexico Postpartum Depression Drugs Market by Type
8.4 Rest of North America Postpartum Depression Drugs Market
- 8.4.1 Rest of North America Postpartum Depression Drugs Market by Treatment
- 8.4.2 Rest of North America Postpartum Depression Drugs Market by Route of Administration
- 8.4.3 Rest of North America Postpartum Depression Drugs Market by Distribution Channel
- 8.4.4 Rest of North America Postpartum Depression Drugs Market by Type

Chapter 9. Company Profiles

9.1 Pfizer, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional & Segmental Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 SWOT Analysis
9.2 Eli Lilly And Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 SWOT Analysis
9.3 Novartis AG
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
9.4 GlaxoSmithKline PLC (GSK)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
9.5 Merck & Co., Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
9.6 Biogen, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Trails and Approvals:
- 9.6.6 SWOT Analysis
9.7 Teva Pharmaceutical Industries Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Bausch Health Companies, Inc. (DermTech, Inc.)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 Cipla Limited
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
9.10. Sage Therapeutics, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Research & Development Expenses

LIST OF TABLES

TABLE 1 North America Postpartum Depression Drugs Market, 2020 - 2023, USD Million
TABLE 2 North America Postpartum Depression Drugs Market, 2024 - 2031, USD Million
TABLE 3 North America Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
TABLE 4 North America Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
TABLE 5 North America Pharmacotherapy Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Pharmacotherapy Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Hormonal Therapy Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Hormonal Therapy Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
TABLE 12 North America Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
TABLE 13 North America Oral Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Oral Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Parenteral Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Parenteral Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 20 North America Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 21 North America Hospital Pharmacy Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Hospital Pharmacy Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Retail Pharmacy Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Retail Pharmacy Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Online Pharmacy Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Online Pharmacy Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
TABLE 28 North America Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
TABLE 29 North America Postpartum Anxiety Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Postpartum Anxiety Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Postpartum Blues Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Postpartum Blues Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Postpartum Panic Disorder Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Postpartum Panic Disorder Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Postpartum Psychosis Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Postpartum Psychosis Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Postpartum Depression Drugs Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Postpartum Depression Drugs Market by Country, 2024 - 2031, USD Million
TABLE 43 US Postpartum Depression Drugs Market, 2020 - 2023, USD Million
TABLE 44 US Postpartum Depression Drugs Market, 2024 - 2031, USD Million
TABLE 45 US Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
TABLE 46 US Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
TABLE 47 US Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
TABLE 48 US Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
TABLE 49 US Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 50 US Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 51 US Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
TABLE 52 US Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
TABLE 53 Canada Postpartum Depression Drugs Market, 2020 - 2023, USD Million
TABLE 54 Canada Postpartum Depression Drugs Market, 2024 - 2031, USD Million
TABLE 55 Canada Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
TABLE 56 Canada Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
TABLE 57 Canada Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
TABLE 58 Canada Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
TABLE 59 Canada Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 60 Canada Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 61 Canada Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
TABLE 62 Canada Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
TABLE 63 Mexico Postpartum Depression Drugs Market, 2020 - 2023, USD Million
TABLE 64 Mexico Postpartum Depression Drugs Market, 2024 - 2031, USD Million
TABLE 65 Mexico Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
TABLE 66 Mexico Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
TABLE 67 Mexico Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
TABLE 68 Mexico Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
TABLE 69 Mexico Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 70 Mexico Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 71 Mexico Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
TABLE 72 Mexico Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
TABLE 73 Rest of North America Postpartum Depression Drugs Market, 2020 - 2023, USD Million
TABLE 74 Rest of North America Postpartum Depression Drugs Market, 2024 - 2031, USD Million
TABLE 75 Rest of North America Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
TABLE 76 Rest of North America Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
TABLE 77 Rest of North America Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
TABLE 78 Rest of North America Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
TABLE 79 Rest of North America Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 80 Rest of North America Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 81 Rest of North America Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of North America Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
TABLE 83 Key Information - Pfizer, Inc.
TABLE 84 Key Information - Eli Lilly And Company
TABLE 85 Key Information - Novartis AG
TABLE 86 Key Information - GlaxoSmithKline PLC
TABLE 87 Key Information - Merck & Co., Inc.
TABLE 88 Key Information - Biogen, Inc.
TABLE 89 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 90 key information - Bausch Health Companies, Inc.
TABLE 91 Key Information - Cipla Limited
TABLE 92 Key Information - Sage Therapeutics, Inc.

North America Postpartum Depression Drugs Market Size, Share & Trends Analysis Report By Treatment (Pharmacotherapy, Hormonal Therapy, and Others), By Route of Administration, By Distribution Channel, By Type, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents